시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 생명과학 분석 소프트웨어 시장 규모, 점유율, 동향 분석 : 컴포넌트별, 제품별, 최종사용자별, 딜리버리 모델별, 용도별, 지역별 전망 및 예측(2023-2030년)
Global Life Science Analytics Software Market Size, Share & Trends Analysis Report By Component (Software, and Services), By Product, By End User, By Delivery Model (Cloud, and On-premise), By Application, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1450607
리서치사 : KBV Research
발행일 : 2024년 02월
페이지 정보 : 영문 338 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 4,956,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 5,947,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,326,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

생명과학 분석 소프트웨어 시장 규모는 2030년까지 533억 달러에 달할 것으로 예상되고 있으며, 예측 기간 중 9.3%의 CAGR로 시장 성장을 달성합니다.

KBV Cardinal matrix에 나타난 분석을 기반으로 합니다. Oracle Corporation과 Accenture PLC는 이 시장의 선구자입니다. 2024년 2월, Oracle Corporation의 한 부문인 Oracle Life Sciences는 디지털 임상시험 회사인 Obvio Health USA, Inc.와의 파트너십을 확대했습니다. 이번 파트너십 확대로 양사는 전 세계 임상시험 중 참가자, 임상의, 기기, 실험실 등 다양한 출처의 건강 데이터를 효율적으로 수집, 결합, 분석할 수 있게 되었습니다. 또한 Cognizant Technology Solutions Corporation, IQVIA Holdings, Inc. 및 Wipro Limited와 같은 기업은 시장의 주요 혁신가 중 일부입니다.

시장 성장 요인

생명과학 데이터는 종종 이질적이고 다양한 출처에서 수집되는 경우가 많습니다. 분석 소프트웨어는 이러한 데이터를 처리하고 통합하여 종합적인 시각과 분석을 가능하게 하는 데 도움이 됩니다. 머신러닝 및 데이터 마이닝과 같은 고급 분석을 통해 기존 분석 방법으로는 명확하지 않은 데이터 내의 패턴과 추세를 식별 할 수 있습니다. 따라서 이러한 측면은 시장 성장에 도움이 될 수 있습니다.

맞춤형 의료는 종종 질병의 감수성, 진행 및 치료에 대한 반응에 영향을 미칠 수 있는 유전적 변이를 이해하기 위해 개인의 유전 정보를 분석하는 것을 포함합니다. 분석 툴은 방대한 게놈 데이터 세트에서 관련 패턴을 해석하고 식별하는 데 중요합니다. 따라서 이러한 측면은 생명과학 분석 소프트웨어에 대한 수요를 증가시킬 것으로 보입니다.

시장 성장 억제요인

분석 소프트웨어는 종종 민감한 정보를 처리하고 분석하는 경우가 많습니다. 환자 데이터를 무단 액세스 및 침해로부터 보호하기 위해서는 강력한 암호화 조치와 액세스 제어를 구현하는 것이 필수적입니다. 따라서 이러한 측면은 시장 성장을 저해할 수 있습니다.

시장의 주요 기업은 시장에서 경쟁력을 유지하기 위해 다양한 혁신적인 제품으로 경쟁하고 있습니다. 위 그림은 시장의 일부 주요 기업이 분배하는 매출의 비율을 보여줍니다. 시장의 주요 기업은 다양한 산업 수요를 충족시키기 위해 다양한 전략을 채택하고 있습니다. 시장의 주요 개발 전략은 파트너십, 협업 및 협정입니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요약

제3장 시장 개요

제4장 경쟁 분석 - 세계

제5장 세계 시장 : 컴포넌트별

제6장 세계 시장 : 제품별

제7장 세계 시장 : 최종사용자별

제8장 세계 시장 : 딜리버리 모델별

제9장 세계 시장 : 용도별

제10장 세계 시장 : 지역별

제11장 기업 개요

제12장 생명과학 분석 소프트웨어 시장의 성공 필수 조건

KSA
영문 목차

영문목차

The Global Life Science Analytics Software Market size is expected to reach $53.3 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.

Predictive analytics in sales help forecast demand, optimize inventory levels, and streamline sales planning. Life science companies can leverage these insights to ensure product availability, minimize stockouts, and improve overall supply chain management. Consequently, the sales and marketing support segment is acquiring a 9.8 % share of the market by 2030. Analytics provides a competitive edge by offering insights into market trends, competitor strategies, and pricing dynamics.

The major strategies followed by the market participants are Partnerships, Collaborations & Agreements as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January 2024, Cognizant Technology Solutions Corporation entered into a partnership with Fortera, Inc., a clinical development and patient access solutions provider. Under this partnership, Fortera intends to keep progressing its mission and providing solutions to pharmaceutical, biotechnology, and medical device customers, as well as to the patients served by those customers. In November 2023, Wipro Limited, an IT service and consulting company, entered into a partnership with Amazon Web Services, Inc., a cloud service provider. Under this partnership, Wipro has unveiled the Lab of the Future, with the aim of empowering the life sciences industry with a modern, efficient, and collaborative laboratory solution. Additionally, to deliver advanced lab performance, the companies will utilize generative AI, advanced analytics, and a helpful business strategy.

Based on the Analysis presented in the KBV Cardinal matrix; Oracle Corporation and Accenture PLC are the forerunners in the Market. In February 2024, Oracle Life Sciences, a division of Oracle Corporation, expanded its partnership with Obvio Health USA, Inc., a digital clinical trials company. Through this extended partnership, the companies will make it possible to efficiently gather, combine, and analyze health data from various sources during clinical trials worldwide, including participants, clinicians, devices, and labs. And Companies such as Cognizant Technology Solutions Corporation, IQVIA Holdings, Inc., and Wipro Limited are some of the key innovators in the Market.

Market Growth Factors

Life sciences data is often heterogeneous and comes from disparate sources. Analytics software helps process and integrate this data, allowing for a comprehensive view and analysis. Advanced analytics, including machine learning and data mining, can identify patterns and trends within the data that may not be apparent through traditional analysis methods. Thus, these aspects will assist in the growth of the market.

Personalized medicine often involves analyzing an individual's genetic information to understand the genetic variations that may influence disease susceptibility, progression, and response to treatment. Analytics tools are crucial in interpreting and identifying relevant patterns within vast genomic datasets. Therefore, these aspects will boost the demand for life science analytics software.

Market Restraining Factors

Analytics software often involves the processing and analysis of sensitive information. Implementing robust encryption measures and access controls is essential to protect patient data from unauthorized access or breaches. Hence, these aspects can hamper the growth of the market.

The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Partnerships, Collaborations & Agreements.

By Component Analysis

On the basis of component, the market is divided into software and services. The software segment recorded the maximum 58.56 % revenue share in the market in 2022. There is a heightened emphasis on leveraging data to inform decision-making processes across various aspects of the life sciences, including drug discovery, clinical trials, patient care, and public health. Hence, the segment will grow rapidly in the upcoming years.

By Product Analysis

Based on product, the market is segmented into prescriptive analytics, descriptive analytics, and predictive analytics. In 2022, the prescriptive analytics segment garnered a 28.32 % revenue share in the market. In the pharmaceutical and biotechnology industry, prescriptive analytics aids in optimizing the drug development process. This proactive approach accelerates decision-making and improves the chances of successful drug discovery. Therefore, the segment will expand rapidly in the upcoming years.

By End User Analysis

Based on end user, the market is divided into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. The pharmaceutical and biotechnology companies segment recorded a 52.19 % revenue share in the market in 2022. Analytics tools are utilized to optimize the design and execution of clinical trials. This leads to more cost-effective and efficient clinical trials. Therefore, these aspects will boost the demand in the segment.

By Delivery Model Analysis

Based on delivery model, the market is segmented into on-premises and cloud. The on-premises segment held a 41.7 % revenue share in the market in 2022. On-premises solutions give organizations greater control over their analytics software's customization and configuration. Therefore, owing to these factors, the segment will witness increased demand in the coming years.

By Application Analysis

On the basis of application, the market is divided into research & development, sales and marketing support, regulatory compliance, supply chain analytics, and pharmacovigilance. The research and development segment recorded the 42.44 % revenue share in the market in 2022. Advanced analytics tools enable researchers to analyze vast datasets, including genomics, proteomics, and metabolomics data, leading to identifying potential drug candidates with greater efficiency. Therefore, these factors will assist in the growth of the segment.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a 29.58 % revenue share in the market. European countries have been actively investing in research and development (R&D) initiatives in the life sciences. The demand for analytics software is driven by the need to analyze and derive insights from complex biological data generated through these initiatives. Therefore, these factors will lead to increased demand in the segment.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Life Science Analytics Software Market Report Segmentation

By Component

By Product

By End User

By Delivery Model

By Application

By Geography

Table of Contents

Chapter 1.Market Scope & Methodology

Chapter 2.Market at a Glance

Chapter 3.Market Overview

Chapter 4.Competition Analysis - Global

Chapter 5.Global Life Science Analytics Software Market by Component

Chapter 6.Global Life Science Analytics Software Market by Product

Chapter 7.Global Life Science Analytics Software Market by End User

Chapter 8.Global Life Science Analytics Software Market by Delivery Model

Chapter 9.Global Life Science Analytics Software Market by Application

Chapter 10.Global Life Science Analytics Software Market by Region

Chapter 11.Company Profiles

Chapter 12.Winning Imperatives of Life Science Analytics Software Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기